
    
      The clinical investigation is a multi-center, multi-country, prospective, non-randomized,
      observational study without concurrent or matched controls, designed to evaluate the safety
      and effectiveness of the Trifecta valve. A maximum of 120 subjects requiring aortic valve
      replacement will be implanted at a maximum of 6 investigational sites in Europe. The sample
      size is based on late patient-years of follow-up with a minimum of 400 late patient-years
      experience required.
    
  